Immune Globulin Subcutaneous (Human), 20% Solution Clinical Trials
2 recruitingBiologic
Showing 1–2 of 2 trials
Recruiting
A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency
Primary Immunodeficiency Diseases (PID)
Takeda100 enrolled1 locationNCT06565078
Recruiting
Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy
Hypogammaglobulinemia, Acquired
University of Alberta30 enrolled1 locationNCT06989541